ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation

Stivala, S; Baerenwaldt, A; Codilupi, T; Ghosh, N; Hao-Shen, H; Dirnhofer, S; Dettmer, Matthias; Simillion, C; Chiu, S; Keller, M (2018). ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation. Swiss medical weekly, 148, 28S-28S. EMH Schweizerischer Ärzteverlag

Full text not available from this repository. (Request a copy)

Item Type:

Conference or Workshop Item (Paper)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Dettmer, Matthias

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Matthias Dettmer

Date Deposited:

14 Jan 2019 09:42

Last Modified:

14 Jan 2019 09:42

URI:

https://boris.unibe.ch/id/eprint/122285

Actions (login required)

Edit item Edit item
Provide Feedback